此页面是自动翻译的,不保证翻译的准确性。请参阅 英文版 对于源文本。

Chatbot-delivered Theory-based Online Intervention in Increasing Seasonal Influenza Vaccination Uptake Among Children Aged 3-6 Years

2026年6月30日 更新者:Zixin Wang、Chinese University of Hong Kong

A Randomized Controlled Trial Evaluating a Chatbot-delivered Theory-based Online Intervention in Increasing Seasonal Influenza Vaccination Uptake Among Children Aged 3-6 Years

This randomized controlled trial will compare the efficacy of a Chatbot-delivered stage-of-change-tailored online intervention versus a Chatbot-delivered non-stage-of-change-tailored online intervention for mothers in increasing seasonal influenza vaccination uptake of their children aged 3-6 years. Mothers of children aged 3-6 years will be randomized evenly into either the intervention or the control group.

In the intervention group, the Chatbot will assess mothers' stage of change regarding their children's seasonal influenza vaccination uptake and deliver SOC-tailored interventions through WhatsApp every two weeks for four times.

In the control group, the Chatbot will provide a standard and non-stage-of-change-tailored intervention every two weeks for four times.

All participants will complete three telephone surveys at baseline (T0), after completion of the intervention (T1) and three months after T1 (T2).

研究概览

研究类型

介入性

注册 (估计的)

426

阶段

  • 不适用

联系人和位置

本节提供了进行研究的人员的详细联系信息,以及有关进行该研究的地点的信息。

学习联系方式

参与标准

研究人员寻找符合特定描述的人,称为资格标准。这些标准的一些例子是一个人的一般健康状况或先前的治疗。

资格标准

适合学习的年龄

  • 成人
  • 年长者

接受健康志愿者

是的

描述

Inclusion Criteria:

  • Mothers aged ≥18 years with at least one child aged 3-6 years studying in kindergarten in Hong Kong
  • Cantonese speaking
  • Having smartphone with internet access
  • Already having WhatsApp on the smartphone

Exclusion Criteria:

  • Blindness or deafness
  • The index child has known medical contraindications for seasonal influenza vaccination

学习计划

本节提供研究计划的详细信息,包括研究的设计方式和研究的衡量标准。

研究是如何设计的?

设计细节

  • 主要用途:卫生服务研究
  • 分配:随机化
  • 介入模型:并行分配
  • 屏蔽:单身的

武器和干预

参与者组/臂
干预/治疗
实验性的:Intervention group
Participants in the intervention group will receive chatbot-delivered online interventions tailored to their current stage of change regarding their index child's seasonal influenza vaccination.
The Chatbot will deliver four intervention sessions tailored to participants' current stage of change regarding their index child's seasonal influenza vaccination uptake at Week 0, 2, 4, and 6. Participants will also have access to real-time Question-and-Answer (QA) function provided by the chatbot to address their questions related to seasonal influenza vaccination during the intervention period (week 0-6), and they are free to spend as much time as they want on such function.
有源比较器:Control group
Participants in the control group will receive chatbot-delivered standard and non-stage-of-change-tailored interventions
The Chatbot will automatically send participants a link to access a standard online video at week 0, 2, 4 and 6. Participants will also have access to real-time Question-and-Answer (QA) function provided by the chatbot to address their questions related to seasonal influenza vaccination during the intervention period (week 0-6), and they are free to spend as much time as they want on such function.

研究衡量的是什么?

主要结果指标

结果测量
措施说明
大体时间
Index child's seasonal influenza vaccination uptake reported by his/her mother with validation
大体时间:3 months after completion of the interventions (T2)
The research team will ask the participants whether their index children have taken up seasonal influenza vaccination at T2 (3 months after completion of the interventions) using a validated question through telephone interview. The research team will validate the outcome by requesting participants uploading an image of SIV receipt, while hiding personal identification, via the WhatsApp account used in this project.
3 months after completion of the interventions (T2)

合作者和调查者

在这里您可以找到参与这项研究的人员和组织。

研究记录日期

这些日期跟踪向 ClinicalTrials.gov 提交研究记录和摘要结果的进度。研究记录和报告的结果由国家医学图书馆 (NLM) 审查,以确保它们在发布到公共网站之前符合特定的质量控制标准。

研究主要日期

学习开始 (估计的)

2026年8月1日

初级完成 (估计的)

2027年10月31日

研究完成 (估计的)

2027年10月31日

研究注册日期

首次提交

2026年6月30日

首先提交符合 QC 标准的

2026年6月30日

首次发布 (实际的)

2026年7月7日

研究记录更新

最后更新发布 (实际的)

2026年7月7日

上次提交的符合 QC 标准的更新

2026年6月30日

最后验证

2026年6月1日

更多信息

与本研究相关的术语

其他研究编号

  • HMRF24230092

计划个人参与者数据 (IPD)

计划共享个人参与者数据 (IPD)?

不

药物和器械信息、研究文件

研究美国 FDA 监管的药品

不

研究美国 FDA 监管的设备产品

不

此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.

订阅